Neuroscientific Biopharmaceuticals Ltd has released a press release.
Full Report from Multiple Sclerosis Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuroscientific Biopharmaceuticals Ltd. on 6ix
Earlier from Neuroscientific Biopharmaceuticals
- EmtinB Positive Results in MS
- Final Report received for Glaucoma Study
- Positive Results in MS Study
- Positive Results in Glaucoma Pig Model
- Additional US Patent granted
Later from Neuroscientific Biopharmaceuticals
- Updated Appendix 4C
- Appendix 4E and Annual Report
- Strategic Placement to AlphaSwiss Partners
- NSB to investigate treatment for post-COVID Fibrosis
- Key Executive Appointments to Support Clinical Studies
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals